WINSTON PHARMACEUT COM STK USD0.0001 (WPHM)

0.02
OTC Markets
Prev Close 0.02
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.01 / 0.03
Exchange OTC Markets
Shares Outstanding 77.41B
Market Cap 1.39M
Div & Yield N.A. (N.A)

Winston Pharmaceuticals, Inc. Announces Positive Results Of Phase II Clinical Trial Of Dolorac® Nasal Solution

Winston Pharmaceuticals, Inc. (“Winston”), a specialty pharmaceutical company focused on developing and commercializing novel pain management therapies, announced the results of its Phase II study on its patented...

Winston Pharmaceuticals, Inc. To Present At Lazard Capital Markets 7th Annual Healthcare Conference

Winston Pharmaceuticals, Inc. (“Winston”), a pharmaceutical company focused on developing and commercializing novel pain management therapies today announced that senior management will present at the ...

Winston Laboratories, Inc. Receives Notice Of Compliance In Canada For CIVANEX™ (Civamide Cream) For Treatment Of Osteoarthritis

Winston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc.

Winston Laboratories, Inc. Submits NDA For CIVANEX® (Civamide Cream) For Treatment Of Osteoarthritis

Winston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc.